Amneal Pharmaceuticals's total assets for Q2 2025 were $3.42B, an increase of 1.71% from the previous quarter. AMRX total liabilities were $3.47B for the fiscal quarter, a 1.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.